We serve Chemical Name:5-(aminomethyl)-2-hydroxybenzoic acid CAS:2820-31-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:5-(aminomethyl)-2-hydroxybenzoic acid
CAS.NO:2820-31-7
Synonyms:5-Aminomethyl-2-hydroxy-benzoesaeure;2-Hydroxy-5-aminomethylbenzoesaeure;5-Aminomethyl-salicylsaeure;5-Aminomethyl-2-hydroxy-benzoic acid;5-Amino-methylsalicylic acid
Molecular Formula:C8H9NO3
Molecular Weight:167.16200
HS Code:2922509090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:376.9ºC at 760mmHg
Density:1.388g/cm3
Index of Refraction:1.642
PSA:83.55000
Exact Mass:167.05800
LogP:1.24940
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 5-Aminomethyl-2-hydroxy-benzoesaeure chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,5-Amino-methylsalicylic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,5-Aminomethyl-2-hydroxy-benzoesaeure Use and application,5-Aminomethyl-2-hydroxy-benzoesaeure technical grade,usp/ep/jp grade.
Related News: “The Agency also noted that no effect was seen in the two studies that included patients from EU populations, including the most recent study which involved patients who were receiving the maximum and optimal treatment for their Parkinson’s disease,” EMA said. 1-(1,3-dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-pyrimidin-4-yl)-4-(tetra-O-acetyl-β-D-glucopyranosyl)-thiosemicarbazide manufacturers In picking McNamara for the over-the-counter unit, GSK is once again de facto standing behind Walmsley as the captain of the remaining pharma, which will stay focused on therapeutics and vaccines, despite pressure from Elliott Management to shuffle its top ranks. ethyl 8-bromo-6-methyl-4-oxo-1H-quinoline-3-carboxylate suppliers The Plexxikon patents are for compounds that reduce cancer cell growth by blocking V600E mutated BRAF. Patents were filed as early as 2005. (2-tert-butoxycarbonylamidoethyl) 2,3,4,6-tetra-O-acetyl-β-D-glucopyranoside vendor & factory.
